The propensity score analysis on the efficacy of sivelestat

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 3, 2013, Pages 395-

  Iwata, Kentaro ^a  

^a KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Propensity score analysis; Sivelestat

Indexed keywords

SIVELESTAT;

ACUTE LUNG INJURY; APACHE; DRUG EFFICACY; HUMAN; LETTER; OXYGEN TENSION; PRIORITY JOURNAL; PROPENSITY SCORE; SURVIVAL;

ACUTE LUNG INJURY; FEMALE; GLYCINE; HUMANS; MALE; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84875941259     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.11.002     Document Type: Letter

References (3)

1. Aikawa N., Ishizaka A., Hirasawa H., Shimazaki S., Yamamoto Y., Sugimoto H., et al. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study. Pulm Pharmacol Ther 2011, 24:549-554.
2. Guo S., Fraser M.W. Propensity score analysis. Statistical methods and applications 2010, SAGE Publications, Inc., California.
3. Connors A.F., Speroff T., Dawson N.V., Thomas C., Harrell F.E., Wagner D., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT investigators. JAMA 1996, 276:889-897.